AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 261: F1102-F1109, 1991;
0363-6127/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanese, D. M.
Right arrow Articles by Conger, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanese, D. M.
Right arrow Articles by Conger, J. D.

AJP - Renal Physiology, Vol 261, Issue 6 1102-F1109, Copyright © 1991 by American Physiological Society

ARTICLES

Effects of atriopeptin III on isolated rat afferent and efferent arterioles

D. M. Lanese, B. H. Yuan, S. A. Falk and J. D. Conger
Department of Medicine, University of Colorado Health Sciences Center, Denver.

The effects of atriopeptin III (AP III) on in vitro prepared afferent (AA) and efferent arterioles (EA) from rat kidneys were tested in a system in which lumen diameter could be measured. AP III (10(-13)-10(-7) M) had no effect on lumen diameter of AA that were not preconstricted. When AA were preconstricted with either angiotensin II (ANG II) or norepinephrine (NE), however, AP III increased lumen diameter in a concentration-dependent manner to the preconstriction baseline value. Maximal vasodilation occurred at 10(-10) M AP III. Unlike AA, EA constricted by 50% to 10(-10) M AP III further constricted EA that were pretreated with ANG II or NE. Dilation in ANG II-preconstricted AA to AP III was not inhibited by indomethacin. Constriction of EA to AP III was not altered by [Sar1-Ala8] ANG II, enalapril, OKY 046, or phentolamine. Results indicate that in isolated renal arterioles AP III dilates preconstricted AA but constricts EA that have either not been pretreated or have been preconstricted with other agonists. The effect of AP III on preconstricted AA does not require vasodilator prostaglandin mediation. The constrictor effect of AP III on EA is not dependent on angiotensin, thromboxane, or alpha-adrenergic mediation.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Reslerova and R. Loutzenhiser
Renal microvascular actions of calcitonin gene-related peptide
Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1078 - F1085.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. L. Allgren, T. C. Marbury, S. N. Rahman, L. S. Weisberg, A. Z. Fenves, R. A. Lafayette, R. M. Sweet, F. C. Genter, B. R.C. Kurnik, J. D. Conger, et al.
Anaritide in Acute Tubular Necrosis
N. Engl. J. Med., March 20, 1997; 336(12): 828 - 834.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. Amin, O. A. Carretero, and S. Ito
Mechanisms of Action of Atrial Natriuretic Factor and C-Type Natriuretic Peptide
Hypertension, March 1, 1996; 27(3): 684 - 687.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online